What Kaster Technologies Inc. does

Kaster Technologies Inc. is a Montréal-based, privately held software company founded in 2022 that builds prescriptive AI for short-term production scheduling in large-scale pharmaceutical manufacturing. Its core product, AIM | Pace, is a constraint-based optimization engine that ingests GMP rules, equipment availability, changeover sequencing, shared-resource constraints, labor, and lab/QA release timings to produce executable, real-time daily and weekly production plans. The platform is offered as a subscription and integrates with existing ERP, MES, SCM, and LIMS systems without replacing them; specialized sub-products address sterile injectables, oral solid dosage, biologics and CGT, non-sterile liquids, veterinary, and API/bulk manufacturing, with an industrial laboratory scheduling module (AIM | Labworks) planned for 2026 and an applied research track (AIM | Labs) for co-development with manufacturing partners.

The company sells primarily through direct enterprise sales to large pharmaceutical manufacturers, demonstrated by validation at Canada's largest sterile injectable manufacturing site where it reports 10%+ capacity gain and 20%+ workflow efficiency improvement without additional capital investment. A strategic commercial partnership with OPTEL announced in March 2026 combines OPTEL's validated line data with Kaster's planning engine to deliver up to 20% production capacity gains, and is being promoted at INTERPHEX in New York. Kaster raised approximately $1.17M in February 2026 led by Graphite Ventures with Hidden Layers Capital, operates with 1-10 employees, and is led by founder and CEO Alexandre Clarizio with founding scientific advisor Louis-Martin Rousseau, PhD.

Name

Kaster Technologies Inc.

Legal name

Kaster Technologies

Website

https://kaster.ca

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Kaster Technologies builds prescriptive AI software (AIM | Pace) for short-term production scheduling in large-scale pharmaceutical manufacturing, serving enterprise drug makers across sterile injectables, biologics, OSD, and API production with GMP-aware, real-time planning.

Ownership category

akta.pro rank

Product category

Pharmaceutical Production Planning Software

NAICS

Computer Systems Design and Related Services (5415)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

Keywords

• Pharmaceutical production scheduling
• Prescriptive AI manufacturing
• GMP production planning
• Aseptic drug manufacturing software
• Pharma capacity optimization

Headquarters

HQ city

Montréal

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Software Platform Subscription: Prescriptive AI software platform for pharmaceutical production planning delivered as a subscription service. Deploys quickly with embedded support and evolves with customers through AIM Labs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Kaster Technologies sells AIM | Pace, a prescriptive AI-powered production scheduling platform purpose-built for large-scale pharmaceutical manufacturers. It transforms complex GMP rules, equipment constraints, shared-resource conflicts, and changeover logic into executable, real-time daily and weekly production plans across sterile injectables, oral solid dosage, biologics/CGT, non-sterile liquids, veterinary, and API/bulk manufacturing. The platform is delivered as a subscription with low-friction API-ready integration to existing ERP, MES, SCM, and LIMS systems, and is complemented by AIM | Labworks (industrial laboratory scheduling, launching 2026) and AIM | Labs (applied research and co-development track).

Product overview

Kaster Technologies offers a unified platform architecture centered on AIM | Pace, a prescriptive AI-powered production scheduling engine purpose-built for large-scale pharmaceutical manufacturing. The portfolio includes specialized sub-products for different dosage forms (sterile injectables, oral solids, biologics, non-sterile liquids, veterinary, and API/bulk manufacturing) that all operate on the core AIM | Pace engine. Additional modules include AIM | Labworks (industrial laboratory scheduling, 2026) for coordinating QA/QC labs with production, and AIM | Labs for applied research and co-development with industry partners. The platform emphasizes GMP compliance, constraint-aware optimization, and real-time adaptability without replacing existing ERP or MES systems.

Differentiator

Problem solved

Functional benefit

Brands

• AIM | Pace: AI-powered prescriptive production planning platform for large-scale pharmaceutical manufacturing, designed to optimize scheduling, capacity utilization, and workflow efficiency across various dosage forms including sterile injectables, oral solid dosage, biologics, and more.
• AIM | Labworks
• AIM | Labs

Products and services

• AIM | Pace Prescriptive AI-powered production scheduling platform for large-scale pharmaceutical manufacturing that models GMP, equipment, labor, utilities, and shared-resource constraints into executable daily and weekly plans. Continuously adjusts production schedules in real time across sterile injectables, OSD, biologics, non-sterile liquids, veterinary, and API/bulk manufacturing, integrating with existing ERP/MES systems.
• AIM | Pace for Sterile Injectables Scheduling configuration for aseptic production that coordinates filling rooms, isolators, and shared autoclaves without conflict and integrates GMP constraints, aseptic operator certifications, and QA oversight for zero-tolerance sterile manufacturing environments.
• AIM | Pace for Oral Solid Dosage (OSD) Scheduling platform for high-volume OSD manufacturing handling hundreds of SKUs, shared compression and coating equipment, changeover constraints, and QA dependencies. Optimizes granulation, compression, coating, and batch sequencing at scale.
• AIM | Pace for Biologics & CGT Production scheduling for biologics manufacturing coordinating upstream/downstream timing, buffer prep, suite transitions, and handling 100-500+ SKUs across multiple formats and product families. Enforces buffer/media prep timing, hold rules, and expiry windows.
• AIM | Pace for Non-Sterile Liquid & Specialty Scheduling for specialty and non-sterile liquids including eye drops, nasal sprays, syrups, topicals, creams, and gels. Plans fast-moving shared-line production with cleaning validation, EM rules, and format-specific compliance logic.
• AIM | Pace for Veterinary Pharmaceuticals Scheduling platform for veterinary drug production including injectables, tablets, vaccines, and oral solutions across sterile, non-sterile, and feed-grade formats with seasonal demand planning and GMP compliance.
• AIM | Pace for API & Bulk Manufacturing Scheduling for API and bulk pharmaceutical manufacturing handling multi-day, multi-step campaigns with shared reactors, centrifuges, filters, and dryers. Designed for 500+ SKU planning complexity across synthetic chemical APIs and fermentation-based processes.
• AIM | Labworks Industrial laboratory scheduling module designed to coordinate lab testing, QA release timings, and environmental monitoring with production schedules, planned for 2026 release.
• AIM | Labs Applied research and innovation service for co-developing next-generation planning and optimization models with partners. Provides a sandbox environment for testing models in regulated pharmaceutical contexts and prototyping new tools and features inside live manufacturing environments.

Quantifiable outcome

• 10%+ production capacity gain without CapEx
• +4 more outcomes

Named customers1 record

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature10 records

Partnerships

One partnership is on record.

• OPTELcoreStrategic or Co-development Partner · 17 March 2026Strategic commercial partnership combining OPTEL's validated line data and life sciences expertise with Kaster's AI-powered production planning engine. The integrated solution provides AI-driven production planning intelligence for pharmaceutical manufacturers. Results proven at one of Canada's largest sterile injectable manufacturing sites. Solution available immediately and demonstrated at INTERPHEX in New York.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• PlanetTogether: PlanetTogether is an APS platform purpose-built for manufacturers including pharma and process industries. It competes in the same scheduling and capacity-optimization category as AIM | Pace, particularly for mid-market and enterprise plants.
• AIMMS (AimmsPRO / AIMMS SCAP): AIMMS is an optimization-based supply chain and production planning platform with strong pharma and process-manufacturing references. Its prescriptive modeling capabilities and pharma customer base make it the closest direct peer to Kaster's AIM | Pace.

Emerging players

• ToolsGroup: ToolsGroup delivers AI-driven supply chain and production planning, including for life sciences manufacturers. Its probabilistic planning and service-level optimization overlap with Kaster's prescriptive AI approach for pharma production.
• Tulip Interfaces: Tulip offers frontline operations and manufacturing apps used in pharma production environments. While focused more on operator-driven apps than batch scheduling, it competes for adjacent pharma manufacturing software budget and digital transformation mindshare.

Broad incumbents

• Siemens Opcenter APS (formerly Preactor): Siemens's advanced planning and scheduling suite serves discrete and process manufacturing including pharma. It is the dominant incumbent APS vendor that Kaster's prescriptive AI scheduling would compete against inside pharma IT stacks.
• Aspen Technology (AspenONE): AspenTech's aspenONE suite covers process manufacturing optimization including batch scheduling (Aspen Batch Process Optimizer) used by pharma majors. It is an incumbent supplier of pharma production optimization that Kaster would compete with on advanced scheduling.
• Dassault DELMIA Quintiq: Dassault's DELMIA Quintiq is an enterprise APS platform widely deployed in pharma and process manufacturing. It competes directly for pharma production planning budgets and benefits from deep ERP/MES integration through the broader Dassault portfolio.
• Honeywell Forge for Industries: Honeywell's process industry software, including manufacturing and supply chain modules, serves large pharma producers. It competes for enterprise pharma production planning budgets and brings deep process-industry domain heritage to scheduling and optimization.
• Dassault BIOVIA: BIOVIA provides manufacturing, quality, and lab informatics for life sciences, including production planning modules for pharma. As a sibling to DELMIA within Dassault, it competes for the same pharma production planning and GMP-aware scheduling budgets.
• SAP IBP (Integrated Business Planning): SAP IBP is SAP's flagship supply and production planning suite, already deployed at most large pharma manufacturers. It represents the incumbent planning platform that AIM | Pace would complement or displace inside enterprise pharma IT landscapes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/kaster-technologies
• Xx.com/AppKaster

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kaster Technologies Inc.